
Lederle Pharma Limited
Pharmaceutical company that manufactures, trades, and exports various veterinary and pharmaceutical products.
Pharmaceutical company that manufactures, trades, and exports various veterinary and pharmaceutical products.
Lederle Pharma Limited (LPL) is a Public Limited Indian Non-Government Company incorporated in India on 14 September 2007 and has a history of 17 years and five months. Its registered office is in Delhi, India.
The Corporate was formerly known as Lederle Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹1.25 Cr.
Sanjay Surana, Mehul Surana, and Ajay Surana serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U24233DL2007PLC168221
168221
Public Limited Indian Non-Government Company
14 Sep 2007
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjay Surana ![]() | Director | 26-Oct-2007 | Current |
Mehul Surana ![]() | Director | 12-Jul-2021 | Current |
Ajay Surana ![]() | Director | 01-Jul-2017 | Current |
Lederle Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.26% increase. The company also saw a substantial improvement in profitability, with a 115.56% increase in profit. The company's net worth moved up by a moderate rise of 0.5%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Lederle Pharma had a promoter holding of 35.18% and a public holding of 64.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sanjay Surana and Ajay Surana are mutual person
Sanjay Surana is a mutual person
Sanjay Surana and Mehul Surana are mutual person
Mehul Surana is a mutual person
Ajay Surana is a mutual person
Ajay Surana is a mutual person
₹1.25 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
14 Jun 2010 | The Nainital Bank Limited | ₹1.25 Cr | Open |
Unlock and access historical data on people associated with Lederle Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lederle Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lederle Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Lederle Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Lederle Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Mehul Surana was appointed as a Director was appointed as a Director on 12 Jul 2021 & has been associated with this company since 3 years 7 months .
Ajay Kumar Surana was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 7 years 8 months .
A charge with The Nainital Bank Limited amounted to Rs. 1.25 Cr with Charge ID 10225664 was registered on 14 Jun 2010.
Sanjay Surana was appointed as a Director was appointed as a Director on 26 Oct 2007 & has been associated with this company since 17 years 4 months .
Lederle Pharma Limited was incorporated on 14 Sep 2007.
The authorized share capital of Lederle Pharma Limited is ₹ 1.50 Cr and paid-up capital is ₹ 1.25 Cr.
Currently 3 directors are associated with Lederle Pharma Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Lederle Pharma Limited is A-75 Second Floor Block - A Kirti Nagar, India, Delhi, 110015.
The corporate identification number (CIN) of Lederle Pharma Limited is U24233DL2007PLC168221 and the company number is 168221 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Lederle Pharma Limited has risen by 34.26%.
The financial reports for the fiscal year 2022 indicates that The net worth of Lederle Pharma Limited has experienced an upsurge of 0.50%.
As per the financial statements for fiscal Year 2022, The total open charges for Lederle Pharma Limited amount to ₹ 1.25 Cr.
The most recent Balance Sheet for Lederle Pharma Limited was filed with the ROC on 31 Mar 2024.
SS
US
RS
MS
RH
DG
SS